News and Trends 22 Jun 2023
Alchemab Therapeutics unveils Alzheimer’s candidate
Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, has unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate, at the Antibody Industrial Symposium…